MétaCan
Menu
Back to cohort
Record W4247688514 · doi:10.1016/j.juro.2013.02.2361

1942 BASELINE PROSTATE ATROPHY IS ASSOCIATED WITH REDUCED RISK OF PROSTATE CANCER IN MEN UNDERGOING REPEAT PROSTATE BIOPSY: RESULTS FROM THE REDUCE STUDY

2013· article· en· W4247688514 on OpenAlexaboutno aff
Daniel M. Moreira, J. Curtis Nickel, Leah R. Gerber, Roberto L. Müller, Gerald L. Andriole, Ramiro Castro‐Santamaria, Stephen J. Freedland

Bibliographic record

VenueThe Journal of Urology · 2013
Typearticle
Languageen
FieldMedicine
TopicProstate Cancer Diagnosis and Treatment
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineProstate cancerProstateProstate biopsyBiopsyDutasterideProstate-specific antigenUrologyCancerGynecologyAtrophyInternal medicine

Abstract

fetched live from OpenAlex

You have accessJournal of UrologyProstate Cancer: Detection & Screening (III)1 Apr 20131942 BASELINE PROSTATE ATROPHY IS ASSOCIATED WITH REDUCED RISK OF PROSTATE CANCER IN MEN UNDERGOING REPEAT PROSTATE BIOPSY: RESULTS FROM THE REDUCE STUDY Daniel Moreira, J. Curtis Nickel, Leah Gerber, Roberto Muller, Gerald Andriole, Ramiro Castro-Santamaria, and Stephen Freedland Daniel MoreiraDaniel Moreira Manhasset, NY , J. Curtis NickelJ. Curtis Nickel Ontario, Canada , Leah GerberLeah Gerber Durham, NC , Roberto MullerRoberto Muller Durham, NC , Gerald AndrioleGerald Andriole Saint Louis, MO , Ramiro Castro-SantamariaRamiro Castro-Santamaria King of Prussia, PA , and Stephen FreedlandStephen Freedland Durham, NC View All Author Informationhttps://doi.org/10.1016/j.juro.2013.02.2361AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Atrophy is a very common finding seen in prostates of patients undergoing biopsy. Notably, the clinical significance of prostatic atrophy in negative biopsies for prostate cancer (PCa) has been studied in a limited number of patients. Therefore, we evaluated whether presence and severity of baseline prostate atrophy among men with initial negative biopsy for PCa increased the risk of subsequent PCa detection in a clinical trial with systematic biopsies. METHODS Retrospective analysis of 5848 men 50-75 years-old with prostate-specific antigen (PSA) between 2.5-10ng/mL and a prior negative biopsy in the Reduction by Dutasteride of PCa Events (REDUCE) study who completed at least a 2-year biopsy. Patients previously on 5-alpha reductase inhibitors were excluded. PCa (defined as present or absent) and prostate atrophy (graded as absent, mild, moderate or marked) were assessed by central pathology review. The association of atrophy in baseline prostate biopsies with positive 2- and 4-year repeat biopsy was evaluated with logistic regression controlling for age, race, body-mass index (BMI), family history of PCa, digital rectal exam (DRE), prostate volume, pre-repeat biopsy PSA and treatment arm (dutasteride or placebo). RESULTS Prostate atrophy was detected in 4085 (69.5%) and graded as mild, moderate and marked in 3507 (59.7%), 573 (9.7%) and 5 (0.1%) baseline biopsies, respectively. Patients with atrophy at baseline were significantly older and had larger prostates (all P<0.01). Prostate atrophy was unrelated to race, BMI, family history of PCa, DRE, PSA and treatment arm. At 2-year biopsy, PCa prevalence was 15% (N=878). In univariable and multivariable analysis, presence of baseline prostate atrophy regardless of grade was significantly associated with lower PCa risk (OR=0.607; P<0.001 and OR=0.623; P<0.001, respectively). These results were virtually unchanged at 4-year biopsy. When stratified by severity, both mild and moderate atrophy were independently associated with lower risk of PCa in univariable (mild: OR=0.622; P<0.001 and moderate: OR=0.521; P<0.001) and multivariable analysis (mild: OR=0.639; P<0.001 and moderate: OR=0.536; P<0.001) at 2-year biopsy. Marked prostate atrophy was not analyzed due to low numbers. CONCLUSIONS In a cohort of men undergoing repeat prostate biopsy 2 and 4 years after negative baseline biopsy, baseline prostate atrophy was independently associated with lower PCa risk. Prostate atrophy in a negative biopsy for PCa may lower risk of PCa detection on repeat biopsy. © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 189 Issue 4S April 2013 Page: e796 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.Metrics Author Information Daniel Moreira Manhasset, NY More articles by this author J. Curtis Nickel Ontario, Canada More articles by this author Leah Gerber Durham, NC More articles by this author Roberto Muller Durham, NC More articles by this author Gerald Andriole Saint Louis, MO More articles by this author Ramiro Castro-Santamaria King of Prussia, PA More articles by this author Stephen Freedland Durham, NC More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.270
Teacher spread0.255 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2013
Admission routes1
Has abstractyes

Explore more

Same venueThe Journal of UrologySame topicProstate Cancer Diagnosis and TreatmentFrench-language works237,207